Related Experiment Video
Updated: Apr 5, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Contrast-induced acute kidney injury: the dark side of cardiac catheterization
Insights
Contrast-induced acute kidney injury (CI-AKI) is a risk following cardiac procedures. Early detection using novel biomarkers is crucial for managing CI-AKI and improving patient outcomes.
Area of Science:
- Cardiology
- Nephrology
- Radiology
Background:
- Percutaneous coronary interventions (PCI) improve outcomes but increase contrast media exposure.
- Contrast-induced acute kidney injury (CI-AKI) is linked to adverse events, including chronic kidney disease and mortality.
- Current diagnostic methods, like serum creatinine, are insufficient for early CI-AKI detection.
Purpose of the Study:
- To review current knowledge on CI-AKI.
- To summarize predictors, diagnostic markers, and management strategies for CI-AKI.
- To highlight the role of novel biomarkers in diagnosing CI-AKI and cardiorenal syndrome.
Main Methods:
- Literature review of contemporary research on CI-AKI.
- Synthesis of information on risk factors, diagnostic markers, and preventive/therapeutic strategies.
- Focus on novel biomarkers for early CI-AKI diagnosis.
Main Results:
- CI-AKI poses significant risks beyond immediate renal impairment.
- Serum creatinine is an unreliable marker for early CI-AKI detection.
- Novel biomarkers show promise for early diagnosis and understanding cardiorenal interactions.
Conclusions:
- Effective management of CI-AKI requires understanding its predictors and utilizing advanced diagnostic tools.
- Novel biomarkers are essential for early CI-AKI diagnosis and managing cardiorenal syndrome.
- Further research into prevention and treatment strategies for CI-AKI is warranted.
Abstract:
The rapidly growing number of percutaneous coronary interventions has led to a considerable improvement in the outcome of patients with acute coronary syndromes, yet concurrently exposing patients to enormous volumes of contrast media with the inherent risk of renal function impairment. The issue of contrast-induced acute kidney injury (CI-AKI) is not only associated with direct sequelae such as prolonged hospital stay, but also with increased risk of chronic kidney disease, recurrent acute coronary syndromes, cerebral ischemia, and increased mortality rate. The ubiquitous application of contrast media warrants active search for reliable risk factors, diagnostic markers, preventive measures, and therapeutic modalities that could be used in the management of CI-AKI. The vast majority of CI-AKI incidents remain undiagnosed due to insufficient efficiency of the serum creatinine level as the marker of acute kidney injury. Recently, several novel renal injury biomarkers have been proposed to facilitate early diagnosis of CI-AKI and better reflect the complex interplay between kidney and cardiac pathology, known as cardiorenal syndrome. This review aimed to summarize the contemporary knowledge on predictors, markers, prevention strategies, and management of CI-AKI.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Cardiac Catheterization IV: Nursing Management
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Cardiac Catheterization III: Left Heart Catheterization

